ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

38,893Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 3593

$1.34M Total Retail Price of All Prescriptions

Rank: 70 out of 3593

1,457 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 1,457 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 1,457 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 30,117 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 2,412 1,859 1 5
LISINOPRIL 1,860 1,456 2 2
AMLODIPINE BESYLATE 1,635 1,376 3 3
SIMVASTATIN 1,606 1,274 4 1
LEVOTHYROXINE SODIUM 1,551 1,207 5 4
METFORMIN HCL 1,403 1,069 6 6
ATORVASTATIN CALCIUM 1,101 861 7 15
LOSARTAN POTASSIUM 1,047 919 8 14
LOVASTATIN 1,025 853 9 20
CARVEDILOL 1,011 825 10 23
RANITIDINE HCL 649 508 11 27
CITALOPRAM HBR 645 501 12 25
METOPROLOL TARTRATE 615 476 13 8
ALENDRONATE SODIUM 575 513 14 22
PRAVASTATIN SODIUM 559 419 15 13
HYDROCHLOROTHIAZIDE 550 384 16 10
GABAPENTIN 522 368 17 16
FUROSEMIDE 518 438 18 9
ZOLPIDEM TARTRATE 468 367 19 12
FLUTICASONE PROPIONATE 452 340 20 32
GLIPIZIDE 451 333 21 40
LIPITOR 437 357 22 136
GLIPIZIDE ER 417 376 23 101
TRAMADOL HCL 414 339 24 17
BENAZEPRIL HCL 400 321 25 69
LANTUS 386 229 26 57
CLONIDINE HCL 373 266 27 41
ATENOLOL 346 303 28 11
WARFARIN SODIUM 322 255 29 18
LOSARTAN-HYDROCHLOROTHIAZIDE 317 284 30 48
GLYBURIDE 310 242 R 31 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 308 258 32 26
CLOPIDOGREL 307 236 33 30
GLIMEPIRIDE 295 207 34 44
METOPROLOL SUCCINATE 284 246 35 19
SERTRALINE HCL 276 173 36 28
TIZANIDINE HCL 263 213 37 120
VENTOLIN HFA 262 132 38 80
ENALAPRIL MALEATE 255 181 39 38
PLAVIX 229 192 40 42
FENOFIBRATE 221 147 41 39
ALLOPURINOL 208 198 42 35
HYDROCODONE-ACETAMINOPHEN 205 163 S3 43 7
CLOTRIMAZOLE-BETAMETHASONE 199 144 44 94
DIOVAN 199 168 44 46
ISOSORBIDE MONONITRATE ER 196 169 46 61
ADVAIR DISKUS 186 101 47 47
DONEPEZIL HCL 179 173 48 31
POLYETHYLENE GLYCOL 3350 172 131 49 143
AZITHROMYCIN 170 124 50 34
DOXAZOSIN MESYLATE 168 164 51 63
PANTOPRAZOLE SODIUM 156 98 52 45
MELOXICAM 149 109 53 29
DIGOXIN 147 135 54 58
HYDRALAZINE HCL 146 113 55 107
TAMSULOSIN HCL 142 135 56 33
SINGULAIR 138 75 57 77
LANTUS SOLOSTAR 137 103 58 122
DILTIAZEM 24HR ER 133 81 59 177
AMLODIPINE BESYLATE-BENAZEPRIL 131 127 60 65
CYCLOBENZAPRINE HCL 128 37 R 61 72
INSULIN SYRINGE 127 96 62 91
MONTELUKAST SODIUM 125 81 63 151
TRAZODONE HCL 123 105 64 53
FLUOXETINE HCL 122 77 65 60
GLYBURIDE-METFORMIN HCL 121 99 R 66 95
POTASSIUM CHLORIDE 115 106 67 24
ACETAMINOPHEN-CODEINE 114 89 S3 68 153
MECLIZINE HCL 109 94 69 96
JANUVIA 109 95 69 81
CRESTOR 108 68 71 21
EXELON 108 108 71 123
KLOR-CON 10 101 87 73 114
SPIRONOLACTONE 98 67 74 86
GEMFIBROZIL 97 74 75 88
GLIPIZIDE XL 97 85 75 179
CIPROFLOXACIN HCL 96 76 77 52
PAROXETINE HCL 91 78 78 62
DIOVAN HCT 89 85 79 76
TEMAZEPAM 87 74 80 56
FAMOTIDINE 86 46 81 70
PROAIR HFA 86 51 81 54
EASY TOUCH 84 38 83 302
HUMALOG MIX 75-25 84 48 83 431
ETODOLAC 83 55 85 247
OXYCODONE-ACETAMINOPHEN 81 59 S2 86 93
METHYLPREDNISOLONE 81 57 86 103
CYMBALTA 80 13 88 73
BISOPROLOL FUMARATE 76 76 89 265
HUMALOG 75 41 90 249
MIRTAZAPINE 74 61 91 64
NIFEDIPINE ER 73 73 92 75
ALPRAZOLAM 72 56 93 37
QUETIAPINE FUMARATE 72 44 93 89
HUMULIN 70-30 71 57 95 215
CARTIA XT 70 64 96 299
NITROSTAT 69 49 97 224
DICLOFENAC SODIUM 69 40 97 74
VESICARE 68 61 99 205
ZETIA 67 62 100 110
VERAPAMIL ER 65 52 101 99
ROPINIROLE HCL 63 41 102 144
BUPROPION XL 63 41 102 243
NAMENDA 63 63 102 50
NIFEDIAC CC 62 50 105 360
PREDNISONE 61 44 106 49
IBUPROFEN 60 32 107 43
DILTIAZEM ER 59 37 108 194
SYNTHROID 57 42 109 51
METOCLOPRAMIDE HCL 56 38 110 145
AMOX TR-POTASSIUM CLAVULANATE 54 37 111 138
LORATADINE 54 37 111 129
FINASTERIDE 54 50 111 79
OXYBUTYNIN CHLORIDE 54 46 111 104
LANSOPRAZOLE 53 38 115 113
THEOPHYLLINE ANHYDROUS 52 50 116 286
PROPRANOLOL HCL 51 27 117 181
JANTOVEN 51 40 117 169
ACTOS 50 43 119 133
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 30, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.